Spanish Life Sciences Trend Analysis 2016

The second half of 2015 was hugely successful in terms of private investment in Spanish biotech companies, both in Catalonia and throughout Spain as a whole. Companies raised USD 86.6m in H2 of last year, compared to USD 5.6m in the six months previously. You can download our full trend analysis below. Spanish LS Trend … Continue reading Spanish Life Sciences Trend Analysis 2016

Read more

Discover How Biotechgate Can Help You In-License New Products

One of the key elements of the Biotechgate database is the Licensing Opportunities search feature. This section of Biotechgate gives the user access to over 4,000 licensing opportunities. The user-friendly search format enables you as the user to quickly and precisely identify the most relevant products. The search format has several filters which allow the … Continue reading Discover How Biotechgate Can Help You In-License New Products

Read more

Biotechgate strengthens its UK network – Welcome OBN and Life Sciences Hub Wales

                                      Zurich, March 2016: Venture Valuation’s Biotechgate enters into a partnership with OBN and Life Sciences Hub Wales to create two new directories for biotechnology in the UK; thus enhancing our network of biotech and life science … Continue reading Biotechgate strengthens its UK network – Welcome OBN and Life Sciences Hub Wales

Read more

Biotechgate enters collaboration with Nasdaq GlobeNewswire

Biotechgate, owned by Venture Valuation has partnered with Nasdaq GlobeNewswire to distribute Nasdaq’s GlobeNewswire press releases on Biotechgate and all its related country portals. Through the collaboration, Biotechgate will provide Nasdaq GlobeNewswire with an additional worldwide and focused publication channel. Biotechgate will publish the Biotech and life science related news on its website www.biotechgate.com and … Continue reading Biotechgate enters collaboration with Nasdaq GlobeNewswire

Read more

Danish Life Sciences Trend Analysis 2015

The Danish venture financing remained stable from 2013 to 2015 at around USD 85m. However, private financing of Biotech companies showed a large intercompany variation. Danish LS Trend Analysis 2015   Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

Read more

Sweden Life Sciences Trend Analysis 2015

After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies. … Continue reading Sweden Life Sciences Trend Analysis 2015

Read more

European Life Sciences Report – Site Selection for Life Sciences Companies

Zurich / Singapore, November 2015 – Venture Valuation together with KPMG has released its 2015 Report on “Site Selection for Life Sciences companies in Europe”. The report looks across the European Life Sciences landscape, analysing and comparing 14 European countries. The report looks at the strength of Biotechnology, Medical Technology and Pharma. This second edition … Continue reading European Life Sciences Report – Site Selection for Life Sciences Companies

Read more

Biotechgate down-under – New life sciences directory for Australia

Zurich / Melbourne, November 2015: Venture Valuations Biotechgate and AusBiotech, the Australian Biotech Industry Association, have entered into an agreement to create a comprehensive directory of Australian biotechnology and life science companies and extend the network and reach of Biotechgate. The Australian Life Sciences Directory will have a standalone web address and will also be … Continue reading Biotechgate down-under – New life sciences directory for Australia

Read more